Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Wyeth-Ayerst acquires commercialization rights to rhIL-11

March 19, 1997

Cabergoline launched in U.S.

March 19, 1997

Preliminary clinical results with CI-1000

March 18, 1997

Pharmacokinetics of paracalcin in patients undergoing hemodialysis

March 18, 1997

Osiris Therapeutics awarded SBIR grant for tendon regeneration research

March 17, 1997

Genzyme Transgenics and Fresenius to further development of transgenic albumin

March 17, 1997

MGI Pharma and Schein reach marketing agreement for INFeD

March 14, 1997

MP-52 enters clinic

March 14, 1997

Combination of immunosuppression and rhIL-3 for aplastic anemia

March 14, 1997

SKB discloses improved antihyperlipidemic agent

March 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...